Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Helen Torley
Age : 57
Public asset : 21,368,524 USD
Country of residence : Unknown
Linked companies : Quest Diagnostics Incorporated - Halozyme Therapeutics, Inc.

Biography of Helen Torley 
Helen I. Torley occupies the position of President, Chief Executive Officer & Director at Halozyme Therapeutics, Inc. She is also on the board of Quest Diagnostics, Inc. and Director & Member-Health Section Governing Board at Biotechnology Innovation Organization and Member of The Royal College of Physicians. In the past she was Vice President & GM-United States Bone Health at Amgen, Inc. and Chief Commercial Officer & Executive VP for Onyx Pharmaceuticals, Inc. (a subsidiary of Amgen, Inc.), Vice President-Medical Affairs of Novartis, Inc., Vice President-Medical Affairs for Sandoz SA and Vice President-Cardiovascular & Metabolic Sales at Bristol-Myers Squibb World Wide Medicines Group. She received an undergraduate degree from the University of Glasgow.


Current positions of Helen Torley 
Holdings of Helen Torley 
Helen Torley : Personal Network 
Most Read News 
12/05MUKESH AMBANI : Indian salesmen threaten supply disruptions in protest against Reliance
RE
11/30JACK DORSEY : Jack Dorsey chases crypto, fintech dream post Twitter
RE
12/01JACK DORSEY : Dorsey-led Square rebrands to Block in nod to blockchain
RE
12/07ELON MUSK : Tesla's Musk says Biden's electric vehicle bill should not pass Congress
RE
12/03CATHIE WOOD : Cathie Wood's ARK Innovation fund hits 13-month low in tech selloff
RE
11/26ELON MUSK : Tesla decides against state aid for German battery plant as Musk opposes subsidies
RE
12/02ELON MUSK : Musk exercises more options, sells Tesla shares worth $1.01 billion
RE
11/30Salesforce shares fall on disappointing profit forecast
RE
12/02TILMAN FERTITTA : FAST Acquisition refuses to terminate SPAC merger with Fertitta Entertainment
RE
12/03DAVID HARRISON : U.S. Nonfarm Payrolls Up 210K in November, Unemployment Rate 4.2% -- Update
DJ
More news


© 2021 People and Ownership :   
Helen Torley : Connections 


Latest news about Helen Torley 
11/09INSIDER SELL : Halozyme Therapeutics
MT
09/07INSIDER SELL : Halozyme Therapeutics
MT
06/08SECTOR UPDATE : Health Care Stocks Losing More Ground Just Ahead of Closing Bell
MT
06/08SECTOR UPDATE : Health Care Stocks Retreating Tuesday Afternoon
MT
02/23Halozyme Therapeutics to Seek Acquisitions
CI
02/14INSIDER TRENDS : Insider at Halozyme Therapeutics Acquires Stock Via Conversion of Option/Derivative Security Sells Portion to Pay Tax, Buy Trend Intact
MT
2019Halozyme Names Alison A. Armour as Senior Vice President of Research and Development
CI
More news